The benefits of surveillance data derive from their ability to contribute to the timely detection and characterization of disease outbreaks (or cases). Unless data can contribute to the detection or characterization of at least one disease or type of outbreak, they are of no value.
The costs of surveillance data derive from the money, time, and effort that a biosurveillance organization must invest to develop a systematic method to obtain the data on a routine basis. We note that additional factors, such as the cost of analysis and the cost of false alarms, may be significant as well.
Was this article helpful?